Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma

Traditional treatments for advanced hepatocellular carcinoma (HCC), such as surgical resection, transplantation, radiofrequency ablation, and chemotherapy are unsatisfactory, and therefore the exploration of powerful therapeutic strategies is urgently needed. Immunotherapy has emerged as a promising...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yi, Gao, Yue, Yang, Huan, Hu, Yong, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743634/
https://www.ncbi.nlm.nih.gov/pubmed/36503490
http://dx.doi.org/10.1186/s40779-022-00433-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743634/
https://www.ncbi.nlm.nih.gov/pubmed/36503490
http://dx.doi.org/10.1186/s40779-022-00433-9

Ejemplares similares